Overview of systemic treatment in recurrent and advanced cervical cancer: a primer for radiologists

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1

(2018) Ahmed Mekki et al.   EUROPEAN JOURNAL OF CANCER

The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis

(2018) Chuenkamon Charakorn et al.   GYNECOLOGIC ONCOLOGY

Sarcoidosis-Like Reactions Induced by Checkpoint Inhibitors

(2018) Ioannis Gkiozos et al.   Journal of Thoracic Oncology

Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer

(2017) Tae Hun Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology

(2017) Juliet E. Wolford et al.   Journal of Gynecologic Oncology

Neutropenic enterocolitis

(2017) Fabio G Rodrigues et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

(2016) Stergios Boussios et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Paclitaxel-induced pneumonitis in patients with breast cancer: case series and review of the literature

(2016) Dana Bielopolski et al.   JOURNAL OF CHEMOTHERAPY

Advances in diagnosis and treatment of metastatic cervical cancer

(2016) Haoran Li et al.   Journal of Gynecologic Oncology

Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer

(2016) Mizuki Nishino et al.   JAMA Oncology

Integration of bevacizumab with chemotherapy doublets for advanced cervical cancer

(2015) Lauren S Krill et al.   EXPERT OPINION ON PHARMACOTHERAPY

Anti-VEGF Molecular Targeted Therapies in Common Solid Malignancies: Comprehensive Update for Radiologists

(2015) Sree Harsha Tirumani et al.   RADIOGRAPHICS

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer

(2015) Nirmala Chandralega Kampan et al.   Biomed Research International

Vascular Toxicity Associated With Chemotherapy and Molecular Targeted Therapy: What Should a Radiologist Know?

(2014) Saurabh Rohatgi et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

FIGO staging for carcinoma of the vulva, cervix, and corpus uteri

(2014)   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Evidence-Based Therapy for Recurrent Cervical Cancer

(2014) Bradley J. Monk et al.   JOURNAL OF CLINICAL ONCOLOGY

Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort

(2014) Yazmin Odia et al.   JOURNAL OF NEURO-ONCOLOGY

Improved Survival with Bevacizumab in Advanced Cervical Cancer

(2014) Krishnansu S. Tewari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Imaging Features of Thoracic Metastases from Gynecologic Neoplasms

(2014) Santiago Martínez-Jiménez et al.   RADIOGRAPHICS

Tumor-bowel fistula: what radiologists should know

(2013) Sree Harsha Tirumani et al.   ABDOMINAL IMAGING

Ipilimumab-Associated Colitis: CT Findings

(2013) Kyung Won Kim et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Liver Metastases in the Era of Molecular Targeted Therapy: New Faces of Treatment Response

(2013) Atul Bhanudas Shinagare et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Gallbladder complications associated with molecular targeted therapies: clinical and imaging features

(2013) Sree Harsha Tirumani et al.   CLINICAL IMAGING

Ipilimumab associated hepatitis: imaging and clinicopathologic findings

(2013) Kyung Won Kim et al.   INVESTIGATIONAL NEW DRUGS

Acute pancreatitis associated with molecular targeted therapies: A retrospective review of the clinico-radiological features, management and outcome

(2013) Sree Harsha Tirumani et al.   PANCREATOLOGY

Decade of Molecular Targeted Therapy: Abdominal Manifestations of Drug Toxicities—What Radiologists Should Know

(2012) Stephanie Anne Holler Howard et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Vinorelbine in Cancer Therapy

(2012) Anna Capasso   CURRENT DRUG TARGETS

Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis

(2012) Olusola Adegoke et al.   JOURNAL OF WOMENS HEALTH

Management of recurrent cervical cancer: A review of the literature

(2012) M. Peiretti et al.   SURGICAL ONCOLOGY-OXFORD

Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials

(2011) Xiao Feng Hang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

PET/CT Evaluation of Cervical Cancer: Spectrum of Disease

(2010) Hongju Son et al.   RADIOGRAPHICS

CT Findings of Chemotherapy-induced Toxicity: What Radiologists Need to Know about the Clinical and Radiologic Manifestations of Chemotherapy Toxicity

(2010) Jean M. Torrisi et al.   RADIOLOGY

Evolution of imaging for abdominal perforation

(2010) JP Singh et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Follow-up for women after treatment for cervical cancer: A systematic review

(2009) Laurie Elit et al.   GYNECOLOGIC ONCOLOGY

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

(2009) Bradley J. Monk et al.   JOURNAL OF CLINICAL ONCOLOGY